Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines von Gotto, A.M, Moon, J.E

Volltext

Activity of a streptococcal cholesterol-lowering protein vs. hdl from apo a-i-deficient mice in vitro and in vivo von Rosales, C, Patel, N, Courtney, H, Gotto, A.M, Pownall, H

Volltext

Normalizing effects of bacterial serum opacity factor on plasma lipids, tissues, and atherosclerosis von Yelamanchili, D., Gillard, B.K., Pownall, H.J., Gotto, A.M., Rosales, C.

Volltext

Serum opacity factor normalizes dysfunctional HDL phenotype in SRB1 -/- mice von Yelamanchili, D., Gillard, B.K., Gotto, A.M., Pownall, H.J., Rosales, C.

Volltext

Excess HDL free cholesterol bioavailability drives free cholesterol accretion into macrophages and erythrocytes in SCRAB1-/- mice von Liu, J., Gillard, B.K., Yelamanchili, D., Gotto, A.M., Rosales, C., Pownall, H.J.

Volltext

Bacterial serum opacity factor catalyzes the discordant distribution of plasma proteins: Analysis by asymmetric flow flow-field fractionation (AF4) von Wang, Z., Qi, B., Rosales, C., Yelamanchili, D., Gillard, B.K., Gotto, A.M., Kuklenyik, Z., Barr, J., Rees, J., Pownall, H.J.

Volltext

Elucidating the differential effects of statins on metabolism in pancreatic Β-cells cultured under high and low glucose von Hamilton, J.A., Shah, A., Tasik, G.D., Sao, K., Lin, S.C., Huang, N., Corkey, B., Deeney, J., Hajjar, D.P., Gotto, A.M., Sponseller, C.

Volltext

Effects of different statins on insulin storage and secretion from pancreatic β-cells: mechanisms and clinical implications von Hamilton, J.A., Bodde, J., Tasik, G. Datu, Kolar, E., Burritt, N., Erion, K., Sitaram, M., Deeney, J., Hajjar, D.P., Gotto, A.M., Corkey, B., Sponseller, C.

Volltext

Effect of bempedoic acid on uric acid and gout in 3621 patients with hypercholesterolemia: pooled analyses from phase 3 trials von Ray, K.K, Bakris, G.L, Banach, M, Catapano, A, Duell, P.B, Mancini, G.B.J, Bloedon, L, Feng, A, Gotto Jr, A.M

Volltext

High density lipoprotein interconversions in rat and man as assessed with a novel nontransferable apolipopeptide von Ponsin, G, Pulcinin, T, Sparrow, J.T, Gotto, A.M. Jr, Pownall, H.J

Volltext

2.C.1 New paradigms for reducing atherosclerosis and CHD: Now and into the 21st century von Gotto, A.M.

Volltext

Lipid-lowering trials: What have they taught us about morbidity and mortality? von Gotto, A.M.

Volltext

Clinical events: Vessel wall changes as surrogate market von Gotto, A.M.

Volltext

Targeted prevention for the higher-risk patient von Gotto, A.M.

Volltext

Drugs affecting lipid metabolism: Effects on atherosclerosis progression and clinical events von Gotto, A.M.

Volltext

Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Stud... von Gotto, A.M, Whitney, E, Stein, E.A, Shapiro, D.R, Clearfield, M, Weis, S, Jou, J.Y, Langendörfer, A, Beere, P.A, Watson, D.J, Downs, J.R, de Cani, J.S

Volltext

The conformational properties of human plasma apolipoprotein C-II. A spectroscopic study von W W Mantulin, M F Rohde, A M Gotto, Jr, H J Pownall

Volltext

Lipid-protein interactions in the plasma lipoproteins von Morrisett, J.D., Jackson, R.L., Gotto, A.M.

Volltext

Establishing the benefit of statins in low-to-moderate—risk primary prevention: The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) von Jr, A.M. Gotto

Volltext

Separation of apolipoproteins-a-i and a-ii by ion-paired reversed-phase high-performance liquid chromatography von Hancock, W.S., Pownall, H.J., Gotto, A.M., Sparrow, J.T.

Volltext